.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Covington
Argus Health
Cerilliant
Dow
QuintilesIMS
UBS
Cipla
Healthtrust
Farmers Insurance

Generated: July 25, 2017

DrugPatentWatch Database Preview

CALCIJEX Drug Profile

« Back to Dashboard

What is the patent landscape for Calcijex, and what generic Calcijex alternatives are available?

Calcijex is a drug marketed by Abbvie and is included in one NDA. There are three patents protecting this drug.

The generic ingredient in CALCIJEX is calcitriol. There are ten drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the calcitriol profile page.

Summary for Tradename: CALCIJEX

Patents:3
Applicants:1
NDAs:1
Bulk Api Vendors: see list61
Clinical Trials: see list2
Patent Applications: see list4,309
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CALCIJEX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-001Sep 25, 1986DISCNYesNo► Subscribe► SubscribeY► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-002Sep 25, 1986DISCNYesNo► Subscribe► SubscribeY► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-001Sep 25, 1986DISCNYesNo► Subscribe► SubscribeY► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-001Sep 25, 1986DISCNYesNo► Subscribe► SubscribeY► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-002Sep 25, 1986DISCNYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CALCIJEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-001Sep 25, 1986► Subscribe► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-002Sep 25, 1986► Subscribe► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-002Sep 25, 1986► Subscribe► Subscribe
Abbvie
CALCIJEX
calcitriol
INJECTABLE;INJECTION018874-001Sep 25, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Colorcon
Daiichi Sankyo
Merck
Fuji
Teva
Julphar
Accenture
Fish and Richardson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot